184 related articles for article (PubMed ID: 33540642)
1. Deoxycholic Acid Upregulates Serum Golgi Protein 73 through Activating NF-κB Pathway and Destroying Golgi Structure in Liver Disease.
Yang D; Yao M; Yan Y; Liu Y; Wen X; Chen X; Lu F
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540642
[TBL] [Abstract][Full Text] [Related]
2. Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients.
Gatselis NK; Tornai T; Shums Z; Zachou K; Saitis A; Gabeta S; Albesa R; Norman GL; Papp M; Dalekos GN
World J Gastroenterol; 2020 Sep; 26(34):5130-5145. PubMed ID: 32982114
[TBL] [Abstract][Full Text] [Related]
3. Bile acids are multifunctional modulators of the Barrett's carcinogenesis.
Burnat G; Majka J; Konturek PC
J Physiol Pharmacol; 2010 Apr; 61(2):185-92. PubMed ID: 20436219
[TBL] [Abstract][Full Text] [Related]
4. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of Golgi protein 73 is indicative of a poor outcome in hepatocellular carcinoma.
Jiang K; Li W; Shang S; Sun L; Guo K; Zhang S; Liu Y
Oncol Rep; 2016 Apr; 35(4):2141-50. PubMed ID: 26820712
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of NF-κB by deoxycholic acid induces miR-21/PDCD4-dependent hepatocellular apoptosis.
Rodrigues PM; Afonso MB; Simão AL; Borralho PM; Rodrigues CMP; Castro RE
Sci Rep; 2015 Dec; 5():17528. PubMed ID: 26621219
[TBL] [Abstract][Full Text] [Related]
7. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.
Yang Y; Liu Q; Li Z; Zhang R; Jia C; Yang Z; Zhao H; Ya S; Mao R; Ailijiang T; Bao Y; Zhang H
Carcinogenesis; 2018 Jul; 39(7):900-910. PubMed ID: 29365054
[TBL] [Abstract][Full Text] [Related]
8. The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review.
Yao M; Wang L; Leung PSC; Li Y; Liu S; Wang L; Guo X; Zhou G; Yan Y; Guan G; Chen X; Bowlus CL; Liu T; Jia J; Gershwin ME; Ma X; Zhao J; Lu F
Clin Rev Allergy Immunol; 2018 Apr; 54(2):282-294. PubMed ID: 29256057
[TBL] [Abstract][Full Text] [Related]
9. Possible roles of Golgi protein-73 in liver diseases.
Liu MY; Huang L; Wu JF; Zhang HB; Ai WB; Zhang RT
Ann Hepatol; 2022; 27(5):100720. PubMed ID: 35577277
[TBL] [Abstract][Full Text] [Related]
10. The bile acid deoxycholic acid (DCA) at neutral pH activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro.
Jenkins GJ; Harries K; Doak SH; Wilmes A; Griffiths AP; Baxter JN; Parry JM
Carcinogenesis; 2004 Mar; 25(3):317-23. PubMed ID: 14656946
[TBL] [Abstract][Full Text] [Related]
11. Factors regulating nuclear factor-kappa B activation in esophageal cancer cells: Role of bile acids and acid.
Abdel-Latif MM; Inoue H; Kelleher D; Reynolds JV
J Cancer Res Ther; 2016; 12(1):364-73. PubMed ID: 27072265
[TBL] [Abstract][Full Text] [Related]
12. SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development.
Kang HJ; Chung DH; Sung CO; Yoo SH; Yu E; Kim N; Lee SH; Song JY; Kim CJ; Choi J
Oncotarget; 2017 Apr; 8(16):27263-27276. PubMed ID: 28460481
[TBL] [Abstract][Full Text] [Related]
13. GP73 represses host innate immune response to promote virus replication by facilitating MAVS and TRAF6 degradation.
Zhang X; Zhu C; Wang T; Jiang H; Ren Y; Zhang Q; Wu K; Liu F; Liu Y; Wu J
PLoS Pathog; 2017 Apr; 13(4):e1006321. PubMed ID: 28394926
[TBL] [Abstract][Full Text] [Related]
14. Sodium taurocholate cotransporting polypeptide mediates dual actions of deoxycholic acid in human hepatocellular carcinoma cells: enhanced apoptosis versus growth stimulation.
Jang ES; Yoon JH; Lee SH; Lee SM; Lee JH; Yu SJ; Kim YJ; Lee HS; Kim CY
J Cancer Res Clin Oncol; 2014 Jan; 140(1):133-44. PubMed ID: 24281334
[TBL] [Abstract][Full Text] [Related]
15. Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma.
Liu T; Yao M; Liu S; Wang L; Wang L; Hou J; Ma X; Jia J; Zhao J; Zhuang H; Lu F
Oncotarget; 2017 Mar; 8(10):16498-16506. PubMed ID: 28157705
[TBL] [Abstract][Full Text] [Related]
16. Expression of nuclear factor-kappaB family proteins in hepatocellular carcinomas.
O'Neil BH; Bůzková P; Farrah H; Kashatus D; Sanoff H; Goldberg RM; Baldwin AS; Funkhouser WK
Oncology; 2007; 72(1-2):97-104. PubMed ID: 18025803
[TBL] [Abstract][Full Text] [Related]
17. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease.
Kladney RD; Cui X; Bulla GA; Brunt EM; Fimmel CJ
Hepatology; 2002 Jun; 35(6):1431-40. PubMed ID: 12029628
[TBL] [Abstract][Full Text] [Related]
18. [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma].
Zhao XY; Li N; Ding HG; Jiang FF
Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):943-5. PubMed ID: 21223806
[TBL] [Abstract][Full Text] [Related]
19. GP73 regulates Hepatic Steatosis by enhancing SCAP-SREBPs interaction.
Yang X; Wu F; Chen J; Wang C; Zhu Y; Li F; Hao Q; Duan C; Wang L; Ma X; Zou D; Luo L; Zhao Y; Guan K; Cao Y; Zhang P; Zhou P; Ma S; Yan Z; Li J; Zhang Y; Wei C; Zhong H
Sci Rep; 2017 Nov; 7(1):14932. PubMed ID: 29097707
[TBL] [Abstract][Full Text] [Related]
20. The role of NF-kappaB in hepatocellular carcinoma cell.
Wang J; Huang Q; Chen M
Chin Med J (Engl); 2003 May; 116(5):747-52. PubMed ID: 12875694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
